Search by Drug Name or NDC

    NDC 76420-0617-30 GABAPENTIN 300 mg/1 Details

    GABAPENTIN 300 mg/1

    GABAPENTIN is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Asclemed USA, Inc.. The primary component is GABAPENTIN.

    Product Information

    NDC 76420-0617
    Product ID 76420-617_068d23f0-3994-f3d5-e063-6394a90ae9a4
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name GABAPENTIN
    Proprietary Name Suffix n/a
    Non-Proprietary Name GABAPENTIN
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 300
    Active Ingredient Units mg/1
    Substance Name GABAPENTIN
    Labeler Name Asclemed USA, Inc.
    Pharmaceutical Class Decreased Central Nervous System Disorganized Electrical Activity [PE]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA075360
    Listing Certified Through 2024-12-31

    Package

    NDC 76420-0617-30 (76420061730)

    NDC Package Code 76420-617-30
    Billing NDC 76420061730
    Package 30 CAPSULE in 1 BOTTLE (76420-617-30)
    Marketing Start Date 2023-09-30
    NDC Exclude Flag N
    Pricing Information N/A